Showing results (211-220 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|April 20, 2004
Development and characterization of two human tumor sublines expressing high-grade resistance to the cyanoguanidine CHS 828Joachim Gullbo, Henrik Lövborg, Sumeer Dhar, et al.
Anti-Cancer Drugs|April 20, 2004
Effects of a combination of exemestane and paclitaxel on human tumor cells in vitroDanqing Chen, Wolfgang Hackl, Olaf Ortmann, et al.
Anti-Cancer Drugs|April 20, 2004
The importance of DT-diaphorase and hypoxia in the cytotoxicity of RH1 in human breast and non-small cell lung cancer cell linesJ Y Kim, A V Patterson, I J Stratford, et al.
Anti-Cancer Drugs|January 19, 2005
Single-agent trastuzumab versus trastuzumab plus cytotoxic chemotherapy in metastatic breast cancer: a single-institution experienceWolfgang J Köstler, Günther G Steger, Michael Krainer, et al.
Anti-Cancer Drugs|January 19, 2005
Long-term remission of excessive liver metastases in a breast cancer patient with chronic alcohol abuse using a monotherapy with trastuzumabMichael H R Eichbaum, Andreas Schneeweiss, Gunther Bastert
Anti-Cancer Drugs|January 19, 2005
The antitumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces NF-kappaB activity in drug-sensitive MCF-7 cellsEileen Brantley, Vyomesh Patel, Sherman F Stinson, et al.
Anti-Cancer Drugs|January 19, 2005
Cytotoxicities of three rebeccamycin derivatives in the National Cancer Institute screening of 60 human tumor cell linesPascale Moreau, Susan Holbeck, Michelle Prudhomme, et al.
Anti-Cancer Drugs|January 19, 2005
Effects of retinoic acid steroidal analogs on human leukemic HL60 cell proliferation in vitro and on angiogenesis in vivoEvaggelia S Arsenou, Evangelia P Papadimitriou, Eleni Kliafa, et al.
Anti-Cancer Drugs|February 16, 2005
In vitro assays for anticancer drug discovery--a novel approach based on engineered mammalian cell linesValeria Gonzalez-Nicolini, Martin Fussenegger
Anti-Cancer Drugs|February 16, 2005
Determinants of trifluorothymidine sensitivity and metabolism in colon and lung cancer cellsOlaf H Temmink, Michiel de Bruin, Elizabeth M Comijn, et al.
Pageof 464